Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Jul 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a golf exercise program can help improve the health and quality of life for men who have survived prostate cancer. The program is designed for men aged 55 to 85 who are currently undergoing treatment for prostate cancer, specifically those receiving hormone therapy for at least six months. Participants should have limited experience with golf—having played five times or less in the past ten years—and must be able to stand on their own without assistance.
By joining this golf program, participants can expect to engage in various physical activities that promote strength, balance, and overall well-being. The researchers aim to see how this recreational exercise affects physical abilities, mental health, and quality of life for prostate cancer survivors. It’s an opportunity for men to stay active, connect with others in a supportive group, and potentially feel better both physically and emotionally.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • First time, primary diagnosis of prostate cancer (PCa)
- • Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months
- • Older adult male: 55-85 years old
- • The ability to stand independently without external support
- • No or minimal golf experience (played \< 5 times in the past 10 years)
- • English speaking
- Exclusion Criteria:
- • Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases
- • Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry)
- • Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) \> 160 or diastolic blood pressure (DBP) \> 90, high resting pulse heart rate (HR) \> 90), symptomatic orthostatic hypotension
- • Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD\]
- • History of injury or orthopedic operation within the last 6 months
- • Movement disorders (e.g., Parkinson's disease (PD) or other neurological disorders), hemiparesis or paraparesis
- • Severe vision or hearing problems
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Los Angeles, California, United States
Patients applied
Trial Officials
George Salem, PhD
Principal Investigator
University of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported